REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
22/12/2025
Voltar para busca
Dado oficial do USPTO
DOSIMYCO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
DOSIMYCO
ST13
US500000088429562Classe
1, 5, 10, 42, 44
Pedido
88429562
Registro
6224908
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
23/12/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 10, 42, 44
Data de depósito
14/05/2019
Data de registro
22/12/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/12/2020
Última transação
23/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Kyoto, JP
Examinador
ANKRAH,NAAKWAMA S
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
S. C. (pessoa física)
Representantes
Tomoko Nakajima Future IP LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical preparations for biological researchbiotechnological researchmedical researchpharmaceutical researchveterinary research useincluding those comprised of natural materialsbut not for purposes of providing medical diagnosis or treatmentexcept fungicides; chemical preparationsstable isotope labeled reference standards for the analytical development of mass spectrometry methods for the biologicalbiotechnologicalmedicalpharmaceuticalveterinary research industries
Classe 5
Diagnostic kits comprised of medical diagnostic chemical reagents for testing of body fluids and body tissue via high pressure liquid chromatographyfor use in detecting immunosuppressantanticoagulantinfectiousparasiticmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricimmune system and nervous system related diseases and disorders; diagnostic kits comprised of medical diagnostic chemical reagents for testing of body fluids and body tissue via liquid chromatography coupled to tandem mass spectrometryfor use in detecting immunosuppressantanticoagulantinfectiousparasiticmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricimmune system and nervous system related diseases and disorders
Classe 10
Medical apparatus and instrumentsapparatus for blood analysismedical diagnostic apparatus for the analysis of body fluids and medical diagnostic apparatus for use in principal component analysis in biology for the analysis of body fluids; vitro diagnostic medical apparatus in the nature of mass spectrometers used in medical facilities
Classe 42
Scientific research and development of molecules suitable for therapeutic use; scientific research and development of new procedures and experiments for the discoveryidentification or improvement of molecules suitable for therapeutic use; scientific and medical laboratory services; engineering services in the field of custom synthesis of molecules suitable for therapeutic use
Classe 44
Medical diagnostic testing services
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/05/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
20/05/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/05/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/05/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
20/05/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
20/05/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/03/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/03/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/03/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/03/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/03/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/03/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29/01/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/01/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
29/01/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29/01/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29/01/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
29/01/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
22/12/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/10/2020
PUBO
PUBLISHED FOR OPPOSITION
06/10/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
31/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/08/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
28/08/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
19/03/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
19/03/2020
CNSI
SUSPENSION INQUIRY WRITTEN
19/03/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
14/03/2020
ALIE
ASSIGNED TO LIE
24/02/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/08/2019
GNSL
LETTER OF SUSPENSION E-MAILED
01/08/2019
CNSL
SUSPENSION LETTER WRITTEN
01/08/2019
DOCK
ASSIGNED TO EXAMINER
30/07/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/05/2019
NWAP
NEW APPLICATION ENTERED
17/05/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DOSIMYCO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.